RPAM
STML

Rhenman & Partners Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Rhenman & Partners Asset Management’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
2020
Q1 		$3.15M Sell
2019
Q4 		$8.08M Buy
2019
Q3 		$5.32M Buy
2019
Q2 		$7.57M Buy